30 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Here's Why Hold Strategy is Apt for EOG Resources (EOG) Stock https://www.zacks.com/stock/news/2280217/here-s-why-hold-strategy-is-apt-for-eog-resources-eog-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2280217 May 28, 2024 - EOG Resources' (EOG) strategic positioning in the U.S. oil markets, with diversified sales to domestic refiners and export-linked capacity, provides a competitive advantage.
Eni (E) Announces Ambitious Share Repurchase Program for 2024 https://www.zacks.com/stock/news/2280213/eni-e-announces-ambitious-share-repurchase-program-for-2024?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2280213 May 28, 2024 - As part of the initial phase of the buyback, Eni (E) will acquire up to 6.4 million of its shares, representing 0.25 of its share capital.
Crude Oil Holding Support: 2 Leading Energy Stocks to Buy Now https://www.zacks.com/commentary/2277549/crude-oil-holding-support-2-leading-energy-stocks-to-buy-now?cid=CS-ZC-FT-investment_ideas-2277549 May 22, 2024 - Marathon Petroleum and Ecopetrol are two market leading companies that enjoy top Zacks Ranks
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug https://www.zacks.com/stock/news/2276833/ptc-therapeutics-ptct-up-as-ec-returns-chmp-opinion-on-dmd-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2276833 May 21, 2024 - PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
ExxonMobil (XOM), Pertamina Progress on CCS Hub in Indonesia https://www.zacks.com/stock/news/2276269/exxonmobil-xom-pertamina-progress-on-ccs-hub-in-indonesia?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2276269 May 20, 2024 - A joint study by Pertamina and ExxonMobil (XOM) estimates the basin to store up to three gigatons of carbon dioxide, potentially requiring an investment of $2 billion.
Here's Why Hold Strategy Is Apt for BP Shares Right Now https://www.zacks.com/stock/news/2275696/here-s-why-hold-strategy-is-apt-for-bp-shares-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2275696 May 17, 2024 - BP's focus on operational efficiency and cost management is set to yield at least $2 billion in cash cost savings by the end of 2026.
Enbridge (ENB) Plans Equity Offering to Fund Major Acquisition https://www.zacks.com/stock/news/2275691/enbridge-enb-plans-equity-offering-to-fund-major-acquisition?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2275691 May 17, 2024 - The shares will be offered at Enbridge's (ENB) discretion, allowing sales to the public intermittently at current market prices.
Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion https://www.zacks.com/stock/news/2249839/bristol-myers-bmy-wins-ec-nod-for-reblozyl-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249839 Apr 03, 2024 - Bristol Myers (BMY) receives European Commission's approval for a label expansion of Reblozyl (luspatercept) for another indication.
Ecopetrol (EC) Wins Dispute, Awarded McDermott Share Capital https://www.zacks.com/stock/news/2246882/ecopetrol-ec-wins-dispute-awarded-mcdermott-share-capital?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2246882 Mar 27, 2024 - Ecopetrol's (EC) Reficar receives the 19.9% convertible preferred shares of McDermott International under a financial restructuring plan proposed by its subsidiary, CB&I N.V.
Ecopetrol S.A. (EC) Q4 2023 Earnings Call Transcript https://seekingalpha.com/article/4675412-ecopetrol-s-ec-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Mar 01, 2024 - Ecopetrol S.A. (NYSE:NYSE:EC) Q4 2023 Earnings Call Transcript March 1, 2024 9:00 AM ETCompany ParticipantsRicardo Roa - CEOAlberto Consuegra - COODavid...

Pages: 123

<Page 2